NCT00208143View on ClinicalTrials.gov

Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

December 31, 2005

Conditions

SchizophreniaSchizoaffective DisorderSubstance AbuseSubstance Dependence

Interventions

DRUG

Quetiapine

DRUG

Risperidone

Trial Locations (1)

68131

Creighton University Psychiatry and Research Center, Omaha

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Creighton University

OTHER